Biography
Dr Richard Shaffer is a Radiation Oncologist with specialist expertise in the use of radiotherapy for the treatment of benign conditions, including Dupuytren’s Disease, Ledderhose Disease, Plantar Fasciitis, Achilles Tendinopathy, Keloid Scarring, Osteoarthritis, Tendinopathy and Bursitis. Since commencing practice in 2011, he has treated approximately 3,000 patients with benign conditions.
He provides training and mentoring to fellow consultants starting benign radiotherapy practices and is founder and CEO of the Radiotherapy Academy for Benign Conditions.
He is the founder and President of the International Society for Radiotherapy for Benign Conditions and is also Medical Director of XStrahl Limited.
He co-wrote the 2015 Royal College of Radiologists guidelines for benign conditions and has written and reviewed multiple scientific papers and textbook chapters and contributed to NICE consultations.
In his early career, Dr Shaffer trained as a specialist registrar at various London teaching hospitals and completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada.
Visit here to understand more about radiotherapy for benign conditions including Osteoarthritis, Plantar Fasciitis, Ledderhose and Dupuytren’s Disease.
GMC: 4552635
Publications
Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation. Stephanie McKeown, Paul Hatfield, Robin Prestwich, Richard Shaffer, Roger Taylor. British Journal of Radiology 2015; 88: 20150405.
A review of the use of radiotherapy in the UK for the treatment of benign clinical conditions and benign tumours. Royal College of Radiologists 2015.
Outcomes of Radiotherapy for Ledderhose disease (Plantar Fibromatosis) of the feet. Richard Shaffer, Immanuel Jeevarathnam, Chelsea Freeland, Louise Pardon. ESTRO meeting (poster) 2018
Treatment of Dupuytren’s Disease with Post-Interventional Radiotherapy. R. Shaffer and H. Seegenschmiedt. ASTRO (poster) 2022